Novadip Biosciences
Dr. Bizet joined the company’s board of directors in 2015. Dr. Bizet joined New Science Ventures in 2015 and is currently also a non-executive director on several company boards. Previously Dr. Bizet was CEO of GIB Group and D’leteren, two listed companies on Euronext-Brussels. Prior to that, he was a senior partner at McKinsey and Company. Dr. Bizet holds a PhD in applied economics from Université Libre de Bruxelles, an MBA from Harvard Business School, and a MS from Solvay Brussels School of Economics and Management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Novadip Biosciences
Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.